- Home
- MGRM vs NVCT Comparison
MGRM vs NVCT Comparison
Compare MGRM & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRM
- NVCT
- Stock Information
- Founded
- MGRM 2016
- NVCT 2020
- Country
- MGRM United States
- NVCT United States
- Employees
- MGRM N/A
- NVCT N/A
- Industry
- MGRM Medical/Dental Instruments
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- MGRM Health Care
- NVCT Health Care
- Exchange
- MGRM Nasdaq
- NVCT Nasdaq
- Market Cap
- MGRM 198.9M
- NVCT 167.0M
- IPO Year
- MGRM N/A
- NVCT 2022
- Fundamental
- Price
- MGRM $5.94
- NVCT $6.52
- Analyst Decision
- MGRM Strong Buy
- NVCT Strong Buy
- Analyst Count
- MGRM 1
- NVCT 3
- Target Price
- MGRM $5.40
- NVCT $15.33
- AVG Volume (30 Days)
- MGRM 127.1K
- NVCT 89.6K
- Earning Date
- MGRM 08-15-2025
- NVCT 11-04-2025
- Dividend Yield
- MGRM N/A
- NVCT N/A
- EPS Growth
- MGRM N/A
- NVCT N/A
- EPS
- MGRM N/A
- NVCT N/A
- Revenue
- MGRM N/A
- NVCT N/A
- Revenue This Year
- MGRM N/A
- NVCT N/A
- Revenue Next Year
- MGRM N/A
- NVCT N/A
- P/E Ratio
- MGRM N/A
- NVCT N/A
- Revenue Growth
- MGRM N/A
- NVCT N/A
- 52 Week Low
- MGRM $1.92
- NVCT $4.44
- 52 Week High
- MGRM $6.02
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- MGRM 73.81
- NVCT 46.13
- Support Level
- MGRM $5.34
- NVCT $6.32
- Resistance Level
- MGRM $6.02
- NVCT $6.90
- Average True Range (ATR)
- MGRM 0.14
- NVCT 0.33
- MACD
- MGRM 0.02
- NVCT 0.05
- Stochastic Oscillator
- MGRM 89.33
- NVCT 51.90
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.